There has been an explosion of knowledge (human genetics) about the delivery of genetics services since Sarah Lawrence College offered the first Master's level genetic counseling program in 1969. Ironically, as the role of genetic testing in modern medical care grows, the number of trained genetic specialists will be insufficient to meet the demand.' Likewise, there has been a proliferation of biotechnology companies marketing genetic testing services to nongeneticist physicians, even though only 19% of these companies believe that such physicians can adequately interpret genetic test r e s~l t s .~ Such beliefs are not intended to disparage the generalist or specialist whose patients need and request genetics services. Non-genetic physicians themselves report a need for more training3,"
In 1995, Garber and Hixon stated that "pregnant patients with concerns about the well-being of their fetuses represent the largest group requiring genetic counseling ~ervices."~ This, combined with the ever increasing understanding of the human genome, only points to the need to establish minimal guidelines for the delivery of prenatal genetics services. Such guidelines would not only serve as an assessment tool for those providing prenatal genetics services, the guidelines help those seeking services to determine the quality and standards that they are receiving. However, developing such guidelines and ensuring voluntary acceptance is no easy task. Guidelines for the appropriate use of genetic tests are currently being developed by both governmental agencies and specialty organi~ations.~ Often such guidelines are specific to one condition, impossible for the general physicians to implement, and even more cumbersome for the consumer of prenatal On the one hand, there seems to be a rush to develop guidelines for any number of medical tests and services. On the other hand, no one organization or body can "enforce" the standards established by the guidelines. Previously, the Great Lakes Regional Genetics Group (GLARGG) has developed guidelines as an ongoing effort of the Evaluation of Clinical Genetics Services Subcommittee to provide assessment of clinical genetics units in our six state region: Illinois, Indiana, Michigan, Minnesota, Ohio, and Wisconsin. The first set of guidelines, "Minimum Guidelines for the Delivery of Clinical Genetics Services," has been used to evaluate centers within this region.1° Each center participates in the evaluation process on a voluntary basis. The on-site evaluations are done by a volunteer peer and/or consumer reviewer from another state.
The same subcommittee has developed a parallel set of minimum guidelines for the Delivery of Prenatal Clinical Genetics Services. These guidelines have been developed by a broad range of genetics professionals and consumers, and are published with the hope that they will stimulate discussion on the need for comprehensive evaluation of prenatal genetics services. We hope they will serve as the basis for developing nationwide standards that promote quality assurance of prenatal clinical genetics services that are understandable and useful to the professional and consumer alike.
GLARGG and its membership welcome and encourage comments about these guidelines and about the wisdom of undertaking quality assurance of prenatal genetics services. Quality assurance guidelines would affect a variety of entities that provide prenatal genetics services: A subsection of a section, a section or division within a department, a department within a school, or a private institution, office, or agency. The guidelines published below are general recommendations for the practice and provision of prenatal clinical genetics services, and while they are intended to promote quality of services along with respect for and collaboration with the patient and family, meeting them does not necessarily assure a good quality of care or a positive patientlfamily experience or outcome. The following guidelines must be met when providing prenatal genetics services. 
Patientlfamily privacy during evaluations and all counseling
sessions is strictly maintained. 5. Considering the fetus of the pregnant female as the index patient, a three generation family pedigree or family history questionnaire is completed and analyzed for every patient. 6. Genetic counseling is provided whenever a prenatal testing procedure is performed. 7. Only cytogenetic results provided by a cytogenetics laboratory certified by the College of American Pathologists are accepted. 8. Written records on all evaluations, counseling sessions, and educational information on testing should be provided to d patients or families, including: Separate, informed consent forms for any procedure performed such as aminocentesis, chorionic villus sampling (CVS), or percutaneous umbilical blood sampling (PUBS); Educational information such as pamphlets or brochures, videotapes, or other media on the procedure prior to the performance of the procedure; Summary of the procedure being performed including follow-up, emergency procedures, and accuracy rates of the test; Follow-up letter reviewing the test results, information presented, and counseling provided should be sent to the patient; and Letter indicating that a patient has received services should be sent to the referring physician. 9. Medical information and/or records should be released only after receipt of written permission from the patient or parents. 10 . At an appropriate time following the provision of services to a patientlfamily, the medical/counseling record should be reviewed. Criteria for the review of the patient's record should be established in writing, and chart deficiencies or problems discovered during the evaluation or follow-up of the patienttfamily should be promptly corrected. 11. A system for handling patient and staff complaints should exist. Complaints should be reviewed at least six times a year, and appropriate decisions should be made about the complaints. 12. A mechanism that ensures adequate follow-up on the evaluation and testing that has been done on patients should exist.
